Lunai Bioworks Inc. Finite-lived Intangible Assets Acquired
Lunai Bioworks Inc. (LNAI) reported Finite-lived Intangible Assets Acquired of $163.62 million for the 12-month period ending 2018-06-30, per its 10-K filed 2018-10-01.
Discontinued › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2018-10-01
- Lunai Bioworks Inc. finite-lived intangible assets acquired for the quarter ending 2018-06-30 was $35.85M.
- Lunai Bioworks Inc. finite-lived intangible assets acquired for fiscal 2018 was $163.62M.
| Period end | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|---|
| 2018-06-30 | $35.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-01 | $163.62M 10-K · filed 2018-10-01 | |
| 2018-03-31 | $127.77M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |